On February 13, image-guided radiotherapy developer ViewRay filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of $69 million.
The company plans to list on the Nasdaq Global Market under the symbol VRAY. No pricing terms were disclosed.



.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=100&q=70&w=100)




.fFmgij6Hin.png?auto=compress%2Cformat&fit=crop&h=167&q=70&w=250)











